Pharmaceutical Technology on MSN
Gene editing takes centre stage in FDA’s new rare disease approval pathway
The aim of the pathway is to remove red tape for bespoke therapies designed for patients with rare diseases.
“We have discovered that people carrying rare, naturally occurring mutations in a gene called CHRNB3 tend to smoke significantly fewer cigarettes per day,” explain the study’s lead authors, ...
Fourth quarter revenue of $198 million, a year-over-year increase of 18% as reported, 14% organic with continued momentum in orders in the ...
Researchers summarize key insights from the world’s first comprehensive investigation into how a pandemic started.
Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsChinmay Shukla - Senior Vice President of ...
Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...
The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...
New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for ...
These "energy blocks" consist of thoughts and viewpoints that dictate how people interpret and experience their lives. When someone is stuck in these patterns, they experience "emotional friction," ...
Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.
Connecting 3,200+ communities and tens of thousands of Texans through a unified, scalable digital wellness platform ...
Neolith’s booth was a standout destination to explore the brand’s newest textures and product innovations, showcased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results